Yang X - Search Results

1

Niemann-Pick disease type C1(NPC1) is involved in resistance against imatinib in the imatinib-resistant Ph+ acute lymphoblastic leukemia cell line SUP-B15/RI.

Naren D, Wu J, Gong Y, Yan T, Wang K, Xu W, Yang X, Shi F, Shi R. Naren D, et al. Among authors: yang x. Leuk Res. 2016 Mar;42:59-67. doi: 10.1016/j.leukres.2016.01.007. Epub 2016 Jan 16. Leuk Res. 2016. PMID: 26818574

2

The study of resistant mechanisms and reversal in an imatinib resistant Ph+ acute lymphoblastic leukemia cell line.

Xing H, Yang X, Liu T, Lin J, Chen X, Gong Y. Xing H, et al. Among authors: yang x. Leuk Res. 2012 Apr;36(4):509-13. doi: 10.1016/j.leukres.2011.12.018. Epub 2012 Jan 29. Leuk Res. 2012. PMID: 22285507

3

[Anti-leukemia effect of oridonin on Ph(+) acute lymphoblastic leukemia cell SUP-B15].

Guo Y, Shan QQ, Gong YP, Lin J, Yang X, Zhou RQ. Guo Y, et al. Among authors: yang x. Zhonghua Xue Ye Xue Za Zhi. 2012 Jun;33(6):439-43. Zhonghua Xue Ye Xue Za Zhi. 2012. PMID: 22967375 Chinese.

4

[Multidrug resistant gene MDR1 contributes to development of imatinib-resistance in Ph (+) acute lymphoblastic leukemia cell line SUP-BS15RI].

Lin J, Xing HY, Gong YP, Yang X, Guo Y, Shan QQ, Zhou RQ. Lin J, et al. Among authors: yang x. Sichuan Da Xue Xue Bao Yi Xue Ban. 2012 Sep;43(5):657-60, 665. Sichuan Da Xue Xue Bao Yi Xue Ban. 2012. PMID: 23230732 Chinese.

5

Mammalian target of rapamycin inhibitor rapamycin enhances anti-leukemia effect of imatinib on Ph+ acute lymphoblastic leukemia cells.

Yang X, He G, Gong Y, Zheng B, Shi F, Shi R, Yang X. Yang X, et al. Eur J Haematol. 2014 Feb;92(2):111-20. doi: 10.1111/ejh.12202. Epub 2014 Jan 6. Eur J Haematol. 2014. PMID: 24112092

6

The antileukemia effect of metformin in the Philadelphia chromosome-positive leukemia cell line and patient primary leukemia cell.

Shi R, Lin J, Gong Y, Yan T, Shi F, Yang X, Liu X, Naren D. Shi R, et al. Among authors: yang x. Anticancer Drugs. 2015 Oct;26(9):913-22. doi: 10.1097/CAD.0000000000000266. Anticancer Drugs. 2015. PMID: 26186064

7

Ribavirin Inhibits the Activity of mTOR/eIF4E, ERK/Mnk1/eIF4E Signaling Pathway and Synergizes with Tyrosine Kinase Inhibitor Imatinib to Impair Bcr-Abl Mediated Proliferation and Apoptosis in Ph+ Leukemia.

Shi F, Len Y, Gong Y, Shi R, Yang X, Naren D, Yan T. Shi F, et al. Among authors: yang x. PLoS One. 2015 Aug 28;10(8):e0136746. doi: 10.1371/journal.pone.0136746. eCollection 2015. PLoS One. 2015. PMID: 26317515 Free PMC article.

8

High-expressing cystic fibrosis transmembrane conductance regulator interacts with histone deacetylase 2 to promote the development of Ph+ leukemia through the HDAC2-mediated PTEN pathway.

Yan T, Leng Y, Yang X, Gong Y, Sun H, Wang K, Xu W, Zheng Y, Naren D, Shi R. Yan T, et al. Among authors: yang x. Leuk Res. 2017 Jun;57:9-19. doi: 10.1016/j.leukres.2017.02.004. Epub 2017 Feb 16. Leuk Res. 2017. PMID: 28235656

9

[Effects of bortezomib combined with daunorubicin on proliferation and apoptosis in primary adult acute leukemia].

Zhou RQ, Gong YP, Zheng BH, Yang X. Zhou RQ, et al. Among authors: yang x. Sichuan Da Xue Xue Bao Yi Xue Ban. 2010 Sep;41(5):789-92. Sichuan Da Xue Xue Bao Yi Xue Ban. 2010. PMID: 21302442 Chinese.

10

[The anti-leukemic effects of imatinib, daunorubicin and bortezomib on two leukemia cell lines with Ph(+)].

Yang X, Yang L, Gong YP, Chang H, Zhou RQ, Xing HY, Zheng BH. Yang X, et al. Among authors: yang l. Sichuan Da Xue Xue Bao Yi Xue Ban. 2010 Sep;41(5):793-6. Sichuan Da Xue Xue Bao Yi Xue Ban. 2010. PMID: 21302443 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75,418 results

Search Page

Filters